Cost-effectiveness of outpatient parenteral antibiotic therapy: a simulation modelling approach | Zendy

Armando VargasPalacios | Zendy; David Meads | Zendy; Maureen Twiddy | Zendy; Carolyn CzoskiMurray | Zendy; Claire Hulme | Zendy; Elizabeth Mitchell | Zendy; Angela Gregson | Zendy; P Stanley | Zendy; Jane Minton | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Cost-effectiveness of outpatient parenteral antibiotic therapy: a simulation modelling approach

Author(s) -

Armando VargasPalacios,

David Meads,

Maureen Twiddy,

Carolyn CzoskiMurray,

Claire Hulme,

Elizabeth Mitchell,

Angela Gregson,

P Stanley,

Jane Minton

Publication year - 2017

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkx123

Subject(s) - medicine , intensive care medicine , antibiotics , antibacterial agent , antibiotic therapy , microbiology and biotechnology , biology

In the UK, patients who require intravenous antimicrobial (IVA) treatment may receive this in the community through outpatient parenteral antimicrobial therapy (OPAT) services. Services include: IVA administration at a hospital outpatient clinic (HO); IVA administration at home by a general nurse (GN) or a specialist nurse (SN); or patient self-administered (SA) IVA administration following training. There is uncertainty regarding which OPAT services represent value for money; this study aimed to estimate their cost-effectiveness.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research